Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. KENIL HEALTHCARE PRIVATE LIMITED
WARNING LETTER
•KENIL HEALTHCARE PRIVATE LIMITED•December 11, 2024

KENIL HEALTHCARE PRIVATE LIMITED – FDA Warning Letter, Dec 11, 2024

Record Details

On June 12, 2025, the FDA issued a Warning Letter to Kenil Healthcare Private Limited, following an inspection from December 5-11, 2024, at their drug manufacturing facility in Gujarat, India. The letter identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR parts 210 and 211), rendering their drug products adulterated under section 501(a)(2)(B) of the FD&C Act.

Key violations include: 1. **Failure to adequately clean and maintain equipment and facilities (21 CFR 211.67(a))**: Investigators observed mold, dirt, soiled air handling units, and product buildup in filling rooms and on equipment. The firm lacked validated cleaning procedures and proper documentation. The FDA deemed the firm's response inadequate, citing a lack of supporting data and failure to assess the impact on distributed products. 2. **Inadequate facility space to prevent mix-ups and contamination (21 CFR 211.42(b))**: Employees performed manual packaging on the floor, multiple drug products were packaged simultaneously without adequate separation, and reserve samples were improperly stored and commingled with expired products. The firm's response regarding warehouse expansion and updated procedures was deemed insufficient for interim controls. 3. **Quality Control Unit failure to ensure CGMP compliance (21 CFR 2

Company
KENIL HEALTHCARE PRIVATE LIMITED
Inspection date
December 11, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · fa3133eb-af83-4cbf-ac8f-7f35ef0dd1d0

Violation Codes10
21 CFR 211.100(a)21 CFR 211.166(a)21 U.S.C. 331(a)21 CFR 211.100(b)21 CFR 21121 CFR 211.67(a)21 CFR 211.18821 CFR 211.42(b)21 CFR 21021 CFR 211.192

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore KENIL HEALTHCARE PRIVATE LIMITED
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.